Hubert E. Huckel M.D. is Director at Valera Pharmaceuticals Inc (VLRX). They have made 9 open-market trades across 3 companies since 2006, most recently 2014-10-02.
CIK 0001121608
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
8 open-market purchases totalling $740K since 2006, against 1 sale. Across 8 scored buys the stock is down 6.1% at ninety days, and 6.4 points behind the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 25% | 25% |
| Avg Move | -20.3% | -6.1% | -6.1% |
| Alpha | -17.4% | -6.4% | -6.4% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CPRX | BUY | 2012-05-24 | 2012-05-29 | $0.80 | $100K | -17.6% | -4.9% | -4.9% |
| CPRX | BUY | 2008-12-18 | 2008-12-23 | $1.73 | $9K | -17.6% | -4.9% | -4.9% |
| CPRX | BUY | 2008-02-07 | 2008-02-11 | $3.45 | $49K | -17.6% | -4.9% | -4.9% |
| CPRX | BUY | 2008-01-30 | 2008-02-01 | $3.05 | $33K | -17.6% | -4.9% | -4.9% |
| CPRX | BUY | 2008-01-30 | 2008-02-05 | $3.25 | $35K | -17.6% | -4.9% | -4.9% |
| KOOL | BUY | 2007-11-16 | 2007-11-20 | $1.95 | $284K | -25.7% | +0.4% | +0.4% |
| VLRX | SELL | 2007-02-26 | 2007-02-28 | $8.29 | $209K | -23.3% | -25.1% | -25.1% |
| KOOL | BUY | 2006-05-12 | 2006-05-15 | $4.02 | $201K | -25.7% | +0.4% | +0.4% |
| VLRX | BUY | 2006-02-02 | 2006-02-02 | $9.00 | $30K | -23.3% | -25.1% | -25.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.